e Reverse protein By www.freepatentsonline.com Published On :: Tue, 12 Feb 2013 08:00:00 EST A protein which is composed N-terminally of one or several C-terminal parts of the amino acid sequence of the mature tumor necrosis factor and C-terminally of one or several N-terminal parts of the amino acid sequence of the mature tumor necrosis factor, which activates epithelial ion channels and improves the lung function and which can be used for the manufacture of medicaments for the treatment of diseases associated with the lung function, such as oedemas. Full Article
e Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis By www.freepatentsonline.com Published On :: Tue, 26 Mar 2013 08:00:00 EDT The present invention relates to fusion proteins comprising an antibody, functional fragment or functional derivative thereof having specific binding affinity to either the extracellular domain of oncofetal fibronectin (ED-B) or at least one of the extracellular domains of oncofetal tenascin fused to a cytokine selected from the group consisting of IL-10, IL15, IL-24 and GM-CSF, functional fragments and functional derivatives thereof. The invention is also directed to the use of at least one of said fusion proteins for the manufacture of a medicament. In particular, the invention concerns the use of said medicament for the treatment of tumors or chronic inflammatory diseases such as atherosclerosis, arthritis and psoriasis. Full Article
e Antibiotic compositions for the treatment of gram negative infections By www.freepatentsonline.com Published On :: Tue, 09 Apr 2013 08:00:00 EDT Provided herein are novel compounds and novel protected compounds that can be derived from polymyxin, including, e.g., polymyxin A. The novel compounds have antibacterial properties against a diverse range of Gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin A. Also provided are antibacterial pharmaceutical compositions containing the novel compounds and novel protected compounds, as well as methods for preparing the antibacterial compounds and protected compounds. Full Article
e Indolesulfonyl protecting groups for protection of guanidino and amino groups By www.freepatentsonline.com Published On :: Tue, 30 Apr 2013 08:00:00 EDT The invention relates to indolesulfonyl halogenides which are useful for the protection of organic compounds comprising at least one guanidino moiety and/or at least one amino group. The invention further relates to a process for their preparation and their use as protecting reagents. The invention also relates to the process for the protecting reaction and to the protected compounds thereof. Full Article
e Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders By www.freepatentsonline.com Published On :: Tue, 04 Jun 2013 08:00:00 EDT This invention relates to compositions and methods comprising “lymphotoxin-β-receptor blocking agents”, which block lymphotoxin-β receptor signalling. Lymphotoxin-β receptor blocking agents are useful for treating lymphocyte-mediated immunological diseases, and more particularly, for inhibiting Th1 cell-mediated immune responses. This invention relates to soluble forms of the lymphotoxin-β receptor extracellular domain that act as lymphotoxin-β receptor blocking agents. This invention also relates to the use of antibodies directed against either the lymphotoxin-β receptor or its ligand, surface lymphotoxin, that act as lymphotoxin-β receptor blocking agents. A novel screening method for selecting soluble receptors, antibodies and other agents that block LT-β receptor signalling is provided. Full Article
e Heterodimeric peptide compounds displaying NGF activity and their use to treat neurodegenerative disorders By www.freepatentsonline.com Published On :: Tue, 11 Jun 2013 08:00:00 EDT Peptides having a structure characterized by the presence of two loops constrained in cyclic structure by the presence of covalent bonds between amino acid side chains, the amino acid sequences of the first and the second loop being substantially homologues to that of loop 1 (residues 29-38) and of loop 4 (residues 92-97) of NGF, respectively, displaying nerve growth factor (NGF) agonist or partial agonist activity. Full Article
e Immobilizing an entity in a desired orientation on a support material By www.freepatentsonline.com Published On :: Tue, 09 Jul 2013 08:00:00 EDT The present invention relates to the identification and selection of attachment molecules that attach/immobilize an entity having a detectable activity or property on a support in an orientation that provides a detectable activity or property, and to surfaces made of the attachment molecules. Full Article
e Immobilized tumor necrosis factor-α muteins for enhancing immune response in mammals By www.freepatentsonline.com Published On :: Tue, 06 Aug 2013 08:00:00 EDT The present invention provides a method for enhancing an immune response in a mammal to facilitate the elimination of a chronic pathology. The method involves the removal of immune system inhibitors such as soluble TNF receptor from the circulation of the mammal, thus, enabling a more vigorous immune response to the pathogenic agent. The removal of immune system inhibitors is accomplished by contacting biological fluids of a mammal with one or more binding partner(s) such as TNFα muteins capable of binding to and, thus, depleting the targeted immune system inhibitor(s) from the biological fluids. Particularly useful in the invention is an absorbent matrix composed of an inert, biocompatible substrate joined covalently to a binding partner, such as a TNFα mutein, capable of specifically binding to a targeted immune system inhibitor such as soluble TNF receptor. Full Article
e Site-directed pegylation of arginases and the use thereof as anti-cancer and anti-viral agents By www.freepatentsonline.com Published On :: Tue, 13 Aug 2013 08:00:00 EDT Mono-pegylated arginase conjugate and method producing thereof. The mono-pegylated arginase is homogeneous in molecular weight and shows therapeutic effect for treating cancers and viral infections. The method of producing such arginase conjugate has a main step of genetically modifying the gene encoding an arginase so that the PEG moiety can attach to the enzyme at a predetermined, specific intended site. This is achieved by removing the PEG attaching amino acid residues at undesirable sites while keeping (or adding, if necessary) the one at the desirable site of the enzyme. Two exemplary mono-pegylated arginase conjugates so produced are human arginase I (HAI) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys45 of the enzyme and Bacillus caldovelox arginase (BCA) where a polyethylene glycol (PEG) moiety is site-specific covalently bonded to Cys161 of the enzyme. Full Article
e Cardioprotective effects of GHRH agonists By www.freepatentsonline.com Published On :: Tue, 13 Aug 2013 08:00:00 EDT Whether the growth hormone (GH)/Insulin-like growth factor 1(IGF-I) axis exerts cardioprotective effects remains controversial; and the underlying mechanism(s) for such actions are unclear. Here we tested the hypothesis that growth-hormone releasing hormone (GHRH) directly activates cellular reparative mechanisms within the injured heart, in a GH/IGF-I independent fashion. Following experimental myocardial infarction (MI), rats were randomly assigned to receive, during a 4 week period, either placebo (n=14), rat recombinant GH (rrGH, n=8) or JI-38 (n=8; 50 μg/Kg/day), a potent GHRH-agonist. JI-38 did not elevate serum levels of GH or IGF-I, but markedly attenuated the degree of cardiac functional decline and remodeling after injury. In contrast, GH administration markedly elevated body weight, heart weight, circulating GH and IGF-I, but did not offset the decline in cardiac structure and function. Whereas, both JI-38 and GH augmented levels of cardiac precursor cell proliferation, only JI-38 increased anti-apoptotic gene expression. The receptor for GHRH was detectable on myocytes supporting direct activation of cardiac signal transduction. Collectively, these findings demonstrate that within the heart GHRH-agonists can activate cardiac repair following MI, suggesting the existence of a potential signaling pathway based on GHRH in the heart. The phenotypic profile of the response to a potent GHRH agonist has therapeutic implications. Full Article
e DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants By www.freepatentsonline.com Published On :: Tue, 20 Aug 2013 08:00:00 EDT Plant viral vectors have great potential in rapid production of proteins, but no simple. Here a geminivirus-based system for high-yield and rapid production of oligomeric protein complexes, including virus-like particle (VLP) vaccines and monoclonal antibodies (mAbs) is described. In particular, a single vector that contains two non-competing replicons for transient expression in Nicotiana benthamiana leaves is described. The correct assembly of these subunit proteins into functional oligomeric structures (VLPs or full-size mAb) is also described. This system advances plant transient expression technology by eliminating the need for non-competing viruses, and thus, enhances the realistic commercial application of this technology for producing multiple-subunit protein complexes. Full Article
e Method for preventing formation of trisulfide derivatives of polypeptides By www.freepatentsonline.com Published On :: Tue, 10 Sep 2013 08:00:00 EDT A method for reducing or substantially preventing formation of a trisulfide derivative of a polypeptide in a liquid medium containing the polypeptide ijn question comprises stripping the liquid medium with a gas, suitably a chemically unreactive gas such as nitrogen or argon. Full Article
e Methods for treating diabetic foot ulcers By www.freepatentsonline.com Published On :: Tue, 17 Sep 2013 08:00:00 EDT The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers. Full Article
e Primate T-lymphotropic viruses By www.freepatentsonline.com Published On :: Tue, 24 Sep 2013 08:00:00 EDT Disclosed are compositions and methods related to the isolation and identification of the primate T-lymphotropic viruses, HTLV-3 and HTLV-4. The diversity of HTLVs was investigated among central Africans reporting contact with NHP blood and body fluids through hunting, butchering, and keeping primate pets. Herein it is shown that this population is infected with a variety of HTLVs, including two retroviruses; HTLV-4 is the first member of a novel phylogenetic lineage that is distinct from all known HTLVs and STLVs; HTLV-3 falls within the genetic diversity of STLV-3, a group that has not previously been seen in humans. The present disclosure also relates to vectors and vaccines for use in humans against infection and disease. The disclosure further relates to a variety of bioassays and kits for the detection and diagnosis of infection with and diseases caused by HTLV-3 and HTLV-4 and related viruses. Full Article
e Compositions and methods for inhibiting tumor cell growth By www.freepatentsonline.com Published On :: Tue, 24 Sep 2013 08:00:00 EDT The present invention relates to compositions and methods for inhibiting the activity of an enzyme, for example, Protein Kinase B, p70S6K and/or Abl using the catalytic subunit of Protein Kinase A (PKAc), or at least one PKAc fragment or variant PKAc fragment thereof. In this regard, methods for preventing or treating cancer or a neurodegenerative disease or disorder are also provided. Full Article
e Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis By www.freepatentsonline.com Published On :: Tue, 29 Oct 2013 08:00:00 EDT Compositions and methods for the treatment of asthma and inflammatory ocular disorders are disclosed. Full Article
e Treatment of kidney disorders with VIP fragments By www.freepatentsonline.com Published On :: Tue, 29 Oct 2013 08:00:00 EDT The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of kidney disease, in particular kidney fibrosis, and other associated conditions. Full Article
e Methods for producing secreted polypeptides having biological activity By www.freepatentsonline.com Published On :: Tue, 19 Nov 2013 08:00:00 EST The present invention relates to methods for producing a polypeptide having biological activity, comprising: (a) cultivating a fungal host cell in a medium conducive for the production of the polypeptide, wherein the fungal host cell comprises a first polynucleotide encoding the polypeptide operably linked to a second polynucleotide encoding a variant signal peptide or a variant prepropeptide; and (b) isolating the secreted polypeptide having biological activity from the cultivation medium. Full Article
e DNA-binding proteins and uses thereof By www.freepatentsonline.com Published On :: Tue, 19 Nov 2013 08:00:00 EST Disclosed herein are polypeptides, polynucleotides encoding, cells and organisms comprising novel DNA-binding domains, including TALE DNA-binding domains. Also disclosed are methods of using these novel DNA-binding domains for modulation of gene expression and/or genomic editing of endogenous cellular sequences. Full Article
e Methods for treatment using amylin family peptides By www.freepatentsonline.com Published On :: Tue, 03 Dec 2013 08:00:00 EST The present invention relates to novel compounds having a function of a peptide in the amylin family, related nucleic acids, expression constructs, host cells, and processes production of the compounds. The compounds of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk. Full Article
e HCG formulations for achieving weight loss By www.freepatentsonline.com Published On :: Tue, 24 Dec 2013 08:00:00 EST A formulation of human chorionic gonadotropin (HCG) for promoting weight loss comprising reconstituted HCG in an amount sufficient to promote weight loss; at least one vitamin selected from the group consisting of: vitamin B1, vitamin B2, vitamin B3, vitamin B5, vitamin B6, vitamin B7, vitamin B9, and vitamin B12; and at least one dietary supplement selected from the group consisting of: an amino acid, inositol, choline chloride, and L-carnitine. Full Article
e Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid By www.freepatentsonline.com Published On :: Tue, 31 Dec 2013 08:00:00 EST Methods and systems for detecting azetidine-2-carboxylic acid (Aze) in food consumable by humans and animals are provided. Also provided are methods and systems for inactivating Aze in food and byproducts, as well as other methods for the diagnosis, prevention, and treatment of disorders associated with Aze. Full Article
e Methods for treating reperfusion injuries using flagellin By www.freepatentsonline.com Published On :: Tue, 31 Dec 2013 08:00:00 EST The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin. Full Article
e Insect resistant protein and insect-resistance gene encoding the insect-resistant protein By www.freepatentsonline.com Published On :: Tue, 07 Jan 2014 08:00:00 EST An insect-resistant protein exhibiting a sufficient resistance to insects; an insect-resistance gene encoding the insect-resistant protein; a recombinant vector containing the insect-resistance gene; a host cell and a plant cell having the recombinant vector transfected thereinto; a transformant transformed by the insect-resistance gene and a method for producing the same; a protein recovered thereby; and an insect-resistant agent comprising them as active ingredients. In accordance with the present invention, the insect-resistant protein is derived from a plant. Full Article
e Peptide synthesis apparatuses By www.freepatentsonline.com Published On :: Tue, 28 Jan 2014 08:00:00 EST Methods, apparatus, systems, computer programs and computing devices related to biologically assembling and/or synthesizing peptides and/or proteins are disclosed. Full Article
e Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy By www.freepatentsonline.com Published On :: Tue, 04 Feb 2014 08:00:00 EST The invention relates to human medicine and to the use of epidermal growth factor (EGF) for preparing a pharmaceutical composition which is administered by infiltration into the periphery of nerve ganglia and/or trunks for the morphofunctional restoration of peripheral nerves in painful sensory-motor neuropathy as well as manifestations of ischemic neuritis. The invention also includes a composition containing EGF which can be formulated together with anesthetics or analgesics or encapsulated in microspheres and to the use thereof for the morphofunctional restoration of peripheral nerves in painful sensitive-motor-type diabetic neuropathy and the manifestations of ischemic neuritis. Full Article
e Extracellular plant ferredoxin-like protein and uses thereof By www.freepatentsonline.com Published On :: Tue, 18 Feb 2014 08:00:00 EST Disclosed are polypeptides, nucleic acids, and related compositions that render plants resistant to bacterial pathogens. Also disclosed are transgenic plants having the nucleic acids and resistant to bacterial pathogens. Full Article
e Antineoplastic hydrogels, and enzyme-instructed preparations thereof By www.freepatentsonline.com Published On :: Tue, 25 Feb 2014 08:00:00 EST Disclosed is a general methodology to create nano fibers of therapeutic molecules that have a dual role, as both the delivery vehicle and the drug itself. It is shown that with proper molecular design, the integration of enzymatic reaction and self-assembly provides a powerful method to create molecular hydrogels of clinically-used therapeutics without compromising their bioactivities. In addition, the results disclosed herein demonstrate enzyme-instructed self-assembly as a facile strategy for generating the supramolecular hydrogels of molecules that inherently have poor solubility in water. For example, by covalently connecting paclitaxel with a motif that is prone to self-assemble, a hydrogel of paclitaxel can be formed without compromising the activity of the paclitaxel. Full Article
e Polypeptoid pulmonary surfactants By www.freepatentsonline.com Published On :: Tue, 18 Mar 2014 08:00:00 EDT The present invention provides spreading agents based on sequence-specific oligomers comprising a peptoid, a peptide-peptoid chimera, a retropeptoid or a retro(peptoid-peptide) chimera, and methods for using the same, including for the treatment of respiratory distress of the lungs. The spreading agents are sequence-specific oligomers, including retrosequence-specific oligomers, based on a peptide backbone, that are designed as analogs of surfactant protein-B or surfactant protein-C. Full Article
e IL4/IL13 binding repeat proteins and uses By www.freepatentsonline.com Published On :: Tue, 13 May 2014 08:00:00 EDT IL4/IL13-binding proteins comprise binding domains, which inhibit IL4/IL13 binding to IL4Ralpaha and common gamma chain complexes (Type 1) and inhibit IL4 binding to IL4Ralpha and IL13Ralpha1 complexes (Type 2), and IL13 binding to IL13Ralpha1 and/or IL13Ralpha2, are useful in the treatment of cancer, inflammatory, and other pathological conditions, such as allergic or fibrotic conditions, especially pulmonary conditions. Full Article
e Method for controlling fibrosis and other pathological deposits in tissues comprising administering a GHRP-6 composition By www.freepatentsonline.com Published On :: Tue, 13 May 2014 08:00:00 EDT The present invention is related to the use of secretagogue peptides repeatedly administered as part of a pharmaceutical composition that prevent and eradicate the deposition of pathological fibrotic material in parenchymal tissues of internal organs like the liver, lungs, esophagus, small intestine, kidneys, blood vessels, joints, and other systemic forms of cutaneous fibrosis of any etiopathogenesis. Additionally, these peptides prevent and eradicate deposition of amiloid and hyaline materials in any of their correspondent chemical forms and tissue manifestations in the brain, cerebellum, blood vessels, liver, intestines, kidneys, spleen, pancreas, joints and the skin, among others. By this way, cellular, tissular and organ dysfunctions generated by these depositions are corrected. The peptides of the present invention are infiltrated or topically applied, contributing to prevent and eradicate keloids and hypertrophic scars in the skin, derived as sequelae of burns and other cutaneous trauma. Full Article
e Methods for the treatment of aortic fibrosis with VIP fragments By www.freepatentsonline.com Published On :: Tue, 20 May 2014 08:00:00 EDT The invention relates to compositions comprising vasoactive intestinal peptide (VIP) or fragments thereof, and the use of such compositions in the treatment of aortic fibrosis and other associated conditions. Full Article
e Therapeutic agent for fibromyalgia containing etanercept By www.freepatentsonline.com Published On :: Tue, 20 May 2014 08:00:00 EDT Disclosed is a drug effective in the treatment of fibromyalgia. Basically, the disclosed therapeutic agent was created on the basis of experiments showing improvement in symptoms when etanercept was administered to patients suffering from fibromyalgia. Etanercept is known as a therapeutic agent for rheumatoid arthritis, and the JFIQ score of patients not suffering from fibromyalgia improved considerably in the preferred embodiment. In other words, a therapeutic agent for fibromyalgia is disclosed that contains etanercept as an active ingredient in an effective amount. Full Article
e Method of treatment of cancer using guanosine 3', 5' cyclic monophosphate (cyclic GMP) By www.freepatentsonline.com Published On :: Tue, 24 Jun 2014 08:00:00 EDT A method of treating cancer through use of guanosine 3',5'-cyclic monophosphate (cyclic GMP). Cyclic GMP decreases the number of human breast cancer and prostate adenocarcinoma as well as small-cell and squamous lung cells in culture by 30% (1 μM), 84% (1 mM), 31% (1 μM), and 30% (1 μM), respectively. Cyclic GMP decreases DNA synthesis in human pancreatic, breast, and prostate adenocarcinomas as well as small-cell and squamous cell carcinomas of the lung at its 1 μM concentration by 51%, 54%, 56%, 50% and 52%, respectively. Cyclic GMP when infused for one week decreases the tumor volume of human pancreatic adenocarcinomas in athymic mice 95% compared to untreated animals with human pancreatic adenocarcinomas. Full Article
e Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology By www.freepatentsonline.com Published On :: Tue, 01 Jul 2014 08:00:00 EDT A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed, in particular osteoarthritis and skin diseases. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system. Full Article
e Beta-amino acids By www.freepatentsonline.com Published On :: Tue, 08 Jul 2014 08:00:00 EDT Disclosed are β-amino acid monomers containing cylcoalkyl, cycloalkenyl, and heterocylic substituents which encompass the α and β carbons of the peptide backbone and β-polypeptides made from such monomers. Method of generating combinatorial libraries of polypeptides containing the β-peptide residues and libraries formed thereby are disclosed. Full Article
e Method for promoting muscle repair comprising administering G-CSF at the site of injury By www.freepatentsonline.com Published On :: Tue, 23 Sep 2014 08:00:00 EDT The present invention relates to muscle repair promoters for local application that contain a colony-stimulating factor (CSF) as an active ingredient. The muscle repair promoters of the present invention exhibit their effect at low doses, particularly when they are administered intramuscularly. Full Article
e Antibiotic compositions for the treatment of gram negative infections By www.freepatentsonline.com Published On :: Tue, 09 Dec 2014 08:00:00 EST Provided herein are novel compounds and novel protected compounds that can be derived from polymyxin, including, e.g., polymyxin A. The novel compounds have antibacterial properties against a diverse range of Gram negative bacteria and reduced toxicity compared to polymyxins such as polymyxin A. Also provided are antibacterial pharmaceutical compositions containing the novel compounds and novel protected compounds, as well as methods for preparing the antibacterial compounds and protected compounds. Full Article
e Methods for treating myocardial infarction comprising administering an IL-6 inhibitor By www.freepatentsonline.com Published On :: Tue, 03 Feb 2015 08:00:00 EST The present inventors investigated the effects of anti-IL-6 receptor antibodies on improving the condition of infarcted areas in myocardial infarction, and on suppressing left ventricular remodeling after myocardial infarction. As a result, the administration of anti-IL-6 receptor antibodies significantly suppressed the increase of MPO activity in the infarcted area and suppressed myocardial MCP-1 expression in both the infarcted area and the non-infarcted area. Furthermore, echocardiography and histological examinations revealed that cardiac hypertrophy is also suppressed. Full Article
e Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof By www.freepatentsonline.com Published On :: Tue, 03 Feb 2015 08:00:00 EST The present invention provides variable mass labeling reagents, a set of the variable mass labeling reagents, and a multiplexed set of variable mass labeling reagents. Full Article
e Peptoids useful for catalyzing the mineralization of calcium carbonate By www.freepatentsonline.com Published On :: Tue, 10 Feb 2015 08:00:00 EST The present invention provides for a bio-mimetic polymer capable of catalyzing CO2 into a carbonate. Full Article
e Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography By www.freepatentsonline.com Published On :: Tue, 03 Mar 2015 08:00:00 EST The present invention provides processes for the manufacturing of polypeptide conjugates. In particular, the invention provides methods for the purification of polypeptide conjugates, which include at least one polymeric modifying groups, such as a poly(alkylene oxide) moiety. Exemplary poly(alkylene oxide) moieties include poly(ethylene glycol) (PEG) and poly(propylene glycol). In an exemplary process, hydrophobic interaction chromatography (HIC) is used to resolve different glycoforms of glycoPEGylated polypeptides. Full Article
e Methods for treating tourniquet-induced injuries By www.freepatentsonline.com Published On :: Tue, 14 Apr 2015 08:00:00 EDT The present invention relates to treating a tissue in a mammal from the effects of reperfusion using flagellin. Full Article
e Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy By www.freepatentsonline.com Published On :: Tue, 19 May 2015 08:00:00 EDT The present invention is relevant to human medicine, and, in particular, to the use of Epidermal Growth Factor (EGF) in a pharmaceutical composition, said composition is administered through infiltration at the periphery of nerve trunks and/or ganglia, for the morphofunctional restoration of peripheral nerves in painful, sensory-motor neuropathy, as well as ischemic neuritis. It is also relevant to an EGF containing composition, where this molecule can be formulated together with anesthetic or analgesic drugs, or encapsulated in microspheres, and their use for the morphofunctional restoration of peripheral nerves in painful, sensory-motor neuropathy, as well as in ischemic neuritis. Full Article
e Disc device By www.freepatentsonline.com Published On :: Tue, 04 Nov 2014 08:00:00 EST A disc device which takes out a disc stored in a magazine and conveys the disc to any disc drive, in which the magazine comprises a tray which stores a plurality of discs, and a case which has a substantially rectangular parallelepiped shape and which stores the tray. The case has an opening at front face into which the tray can be inserted into or taken out therefrom. The tray has an outer shape being substantially rectangular in planar view. The tray is provided with cut portions formed at corner portions positioned on the back side of the case being cut off. The disc device further comprises a picker which holds the tray and draws out the tray from the case. The picker rotates the tray when the cut portion passes through the opening. Full Article
e Rotary element assembly structure with rotary element capable of rotating about hollow shaft By www.freepatentsonline.com Published On :: Tue, 04 Nov 2014 08:00:00 EST A rotary element assembly structure in which a rotary element 53 is assembled to a tip side of a hollow shaft B1 provided upright on a pedestal 60. A cylindrical portion 53c for fitting with the hollow shaft is provided to a rotation center portion of the rotary element. In the cylindrical portion, a hook strut portion 53s that has a hook portion 53f overhanging in the radial direction at its tip side and that extends substantially in the fitting direction is arranged. A base end portion of the hook strut portion and a base end portion of the cylindrical portion are coupled with each other by a resin-made thin plate portion 53p. A small diameter portion B1s which is smaller in diameter than a hollow portion B1d of the hollow shaft is provided on the tip side of the hollow shaft. The radius of the overhang tip portion of the hook portion is set to be greater than the radius of the small diameter portion of the hollow shaft, and to be smaller than the radius of the hollow portion. By fitting the hollow shaft with the cylindrical portion of the rotary element, the hook portion on the tip side of the hook strut portion is pushed into the hollow portion via the small diameter portion on the tip side of the hollow shaft. Thereby, the hook portion engages with a stepped portion formed by the hollow portion and the small diameter portion. Full Article
e Optical disc device and lens cleaner By www.freepatentsonline.com Published On :: Tue, 11 Nov 2014 08:00:00 EST An optical disc device of the present invention comprises an insertion detection optical sensor which detects insertion of an optical disc based on light emitted from a first light emitting element to a first light receiving element being blocked, and an ejection detection optical sensor provided on the downstream side in the carry-in direction to the insertion detection optical sensor to detect ejection of the optical disc based on light emitted from a second light emitting element to a second light receiving element being blocked. The optical disc device is structured such that, in a state that the optical disc is attached onto the turntable, when the light of the first light emitting element is blocked and the light of the second light emitting element is not blocked, the optical disc device recognizes that a lens cleaner is attached onto the turntable as the optical disc, and the optical disc device performs a cleaning operation. Full Article
e Optical disc drive By www.freepatentsonline.com Published On :: Tue, 18 Nov 2014 08:00:00 EST In an optical disc drive, a degradation of traveling performance of an optical pickup under hard acceleration or hard deceleration in a random access operation or the like results in a degradation of recording/reproducing performance. Groove structure is provided between two gears of a guide feed provided in an optical pickup, and the groove forms bending structure. Thus, the engagement state between a screw gear and the gears of the guide feed is stabilized. This makes it possible to prevent tooth jumping and step-out from occurring in the gears during the traveling of the optical pickup, achieving stable traveling. In consequence, the recoding/reproducing performance of the optical disc drive can be improved. Full Article
e Rotary head data storage and retrieval system and method for data verification By www.freepatentsonline.com Published On :: Tue, 25 Nov 2014 08:00:00 EST A data storage and retrieval system includes a head carriage unit adapted for rotational motion and having multiple heads disposed at a working surface. The system also includes a tape drive unit configured to move a tape media past the working surface of the head carriage unit, the tape media having a width approximately equal to a width of the working surface. As the head carriage unit rotates and the tape moves past the working surface, a first head is configured to write a data track to the tape and a second head is configured to thereafter read the data track, where data read by the second head is for use in verifying data integrity and performing error correction. Full Article
e Cooling in high-density storage systems By www.freepatentsonline.com Published On :: Tue, 25 Nov 2014 08:00:00 EST In one embodiment an enclosure for a high-density storage system, comprises a backplane to which a plurality of data storage devices may be coupled, a front panel opposite the backplane and defining a first airflow channel adjacent a front side of the data storage devices, a back panel opposite the front panel and comprising a second airflow channel adjacent the backplane, a floor panel and a top panel, a first side panel comprising an array of air flow inlets, a second side panel comprising at least one air flow outlet, and a fan assembly to expel air from the at least one air outlet. Full Article